CMCM202206/the Project of Changzhou Medical Center[Grants and Funding] - Search Results

Save citations to file

Your saved search

Your RSS Feed

Year	Number of Results
2023	1
2024	2
2025	1

Page 1

IGF2BP2 Drives Cell Cycle Progression in Triple-Negative Breast Cancer by Recruiting EIF4A1 to Promote the m6A-Modified CDK6 Translation Initiation Process.

Xia T, Dai XY, Sang MY, Zhang X, Xu F, Wu J, Shi L, Wei JF, Ding Q. Xia T, et al. Adv Sci (Weinh). 2024 Jan;11(1):e2305142. doi: 10.1002/advs.202305142. Epub 2023 Nov 20. Adv Sci (Weinh). 2024. PMID: 37983610 Free PMC article.

FANCI Inhibition Induces PARP1 Redistribution to Enhance the Efficacy of PARP Inhibitors in Breast Cancer.

Huang YZ, Sang MY, Xi PW, Xu RX, Cai MY, Wang ZW, Zhao JY, Li YH, Wei JF, Ding Q. Huang YZ, et al. Cancer Res. 2024 Oct 15;84(20):3447-3463. doi: 10.1158/0008-5472.CAN-23-2738. Cancer Res. 2024. PMID: 39037758

IGF2BP3 promotes autophagy-mediated TNBC metastasis via m6A-dependent, cap-independent c-Met translation.

Wang ZW, Li YH, Cai MY, Zhang X, Xu RX, Yang HY, Huang YZ, Shi L, Wei JF, Ding Q. Wang ZW, et al. Cell Commun Signal. 2025 Jul 1;23(1):303. doi: 10.1186/s12964-025-02316-7. Cell Commun Signal. 2025. PMID: 40598509 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year